These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 26269678)

  • 21. A prognostic index for patients within the intermediate stage of hepatocellular carcinoma.
    Di Costanzo GG; Signoriello S; Tortora R; Gallo C
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):592-8. PubMed ID: 26974431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic arterial infusion therapy with a fine powder formulation of cisplatin for advanced hepatocellular carcinoma with portal vein tumor thrombosis.
    Kondo M; Morimoto M; Numata K; Nozaki A; Tanaka K
    Jpn J Clin Oncol; 2011 Jan; 41(1):69-75. PubMed ID: 20688778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Impact of Combined Transarterial Chemoembolization on the Overall Survival of Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib.
    Chen L; Su H; Shao H; Xu K; Liang S; Liu J
    Hepatogastroenterology; 2014 May; 61(131):802-8. PubMed ID: 26176077
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Poor oncologic outcomes of hepatocellular carcinoma patients with intra-abdominal infection after hepatectomy.
    Ruan DY; Lin ZX; Li Y; Jiang N; Li X; Wu DH; Wang TT; Chen J; Lin Q; Wu XY
    World J Gastroenterol; 2015 May; 21(18):5598-606. PubMed ID: 25987785
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival outcomes and prognostic factors of transcatheter arterial chemoembolization for hepatic neuroendocrine metastases.
    Hur S; Chung JW; Kim HC; Oh DY; Lee SH; Bang YJ; Kim WH
    J Vasc Interv Radiol; 2013 Jul; 24(7):947-56; quiz 957. PubMed ID: 23602421
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatic arterial infusion chemotherapy with use of an implanted port system in patients with advanced hepatocellular carcinoma: prognostic factors.
    Hamada A; Yamakado K; Nakatsuka A; Takaki H; Akeboshi M; Takeda K
    J Vasc Interv Radiol; 2004 Aug; 15(8):835-41. PubMed ID: 15297587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polyvinyl alcohol terminal chemoembolization for hepatocellular carcinoma with hepatic arteriovenous shunts: Safety, efficacy, and prognostic factors.
    Liu QS; Mei QL; Li YH
    Eur J Radiol; 2017 Apr; 89():277-283. PubMed ID: 27908612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive treatments for hepatocellular carcinoma with tumor thrombus in major portal vein.
    Ye HH; Ye JZ; Xie ZB; Peng YC; Chen J; Ma L; Bai T; Chen JZ; Lu Z; Qin HG; Xiang BD; Li LQ
    World J Gastroenterol; 2016 Apr; 22(13):3632-43. PubMed ID: 27053855
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy of hepatic arterial infusion chemotherapy with cisplatin for advanced hepatocellular carcinoma].
    Usui T; Shiozawa S; Kim DH; Tsuchiya A; Masuda T; Inose S; Aizawa M; Yoshimatsu K; Katsube T; Naritaka Y; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2702-4. PubMed ID: 21224685
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter arterial chemoembolization therapy using iodized oil for patients with unresectable hepatocellular carcinoma: evaluation of three kinds of regimens and analysis of prognostic factors.
    Ueno K; Miyazono N; Inoue H; Nishida H; Kanetsuki I; Nakajo M
    Cancer; 2000 Apr; 88(7):1574-81. PubMed ID: 10738215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors of spontaneously ruptured hepatocellular carcinoma.
    Han XJ; Su HY; Shao HB; Xu K
    World J Gastroenterol; 2015 Jun; 21(24):7488-94. PubMed ID: 26139994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A prognostic score for patients with intermediate-stage hepatocellular carcinoma treated with transarterial chemoembolization.
    Ogasawara S; Chiba T; Ooka Y; Kanogawa N; Motoyama T; Suzuki E; Tawada A; Azemoto R; Shinozaki M; Yoshikawa M; Yokosuka O
    PLoS One; 2015; 10(4):e0125244. PubMed ID: 25919025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ascites and alpha-fetoprotein improve prognostic performance of Barcelona Clinic Liver Cancer staging.
    Gomaa AI; Al-Khatib A; Abdel-Razek W; Hashim MS; Waked I
    World J Gastroenterol; 2015 May; 21(18):5654-62. PubMed ID: 25987792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of 18F-FDG PET for hepatocellular carcinoma patients treated with sorafenib.
    Lee JH; Park JY; Kim DY; Ahn SH; Han KH; Seo HJ; Lee JD; Choi HJ
    Liver Int; 2011 Sep; 31(8):1144-9. PubMed ID: 21745288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of hepatic resection and transarterial chemoembolization for solitary hepatocellular carcinoma.
    Zhang DZ; Wei XD; Wang XP
    World J Gastroenterol; 2015 Apr; 21(15):4635-43. PubMed ID: 25914473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum C-reactive protein levels predict survival in hepatocellular carcinoma.
    Nagaoka S; Yoshida T; Akiyoshi J; Akiba J; Torimura T; Adachi H; Kurogi J; Tajiri N; Inoue K; Niizeki T; Koga H; Imaizumi T; Kojiro M; Sata M
    Liver Int; 2007 Oct; 27(8):1091-7. PubMed ID: 17845537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.